Remember that when considering such retrospective equivalency assertions, FDA typically demands that the proposed retro alternative use-case(s) involve the same materials, with the same intended medical use (including, but not limited to, the same nature and duration of medical/therapeutic contact in the same or similar parts of the human body), and processed in the same way. So in my experience, FDA would most certainly reject the aircraft/automobile industry uses outright simply because those don't involve clinical/therapeutic use of the materials.
------------------------------
Kevin Randall, ASQ CQA, RAC (U.S., Canada, Europe)
Principal Consultant
ComplianceAcuity, Inc.
Golden CO
United States
www.complianceacuity.com------------------------------
Original Message:
Sent: 27-Sep-2019 08:32
From: Anonymous Member
Subject: biocompatibility materials from different industry
This message was posted by a user wishing to remain anonymous
Hi,
I wonder if any of you has experience with the FDA's thinking on the use of materials (e.g., coating, varnish, etc.) used in aircraft or automobile industry for limited or prolonged skin contact. Which type of evidence on biocompatibility from the supplier - to be included in our risk assessment -could be deemed satisfactory? Could a justification based on history of safe use of this type of material in contact with people be sufficient?